This company webcast features Kairos Pharma (NYSE American: KAPA). Kairos Pharma is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer.
This company webcast was recorded during the Lytham Partners 2025 Investor Healthcare Summit.